Why this ASX infant formula share is sinking lower today

The Clover Corporation Limited (ASX:CLV) share price is pushing higher on Wednesday after the release of its half year results…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Clover Corporation Limited (ASX: CLV) share price is trading lower on Wednesday.

This follows the release of the infant formula ingredients manufacturer's half year results after the market close on Tuesday.

At the time of writing the Clover share price is down almost 6% to $1.76.

How did Clover perform in the first half?

For the six months ended January 31, Clover reported net sales revenue of $37.6 million. This was a 9.8% increase on the prior corresponding period.

However, on the bottom line the company recorded a net profit after tax of $4.6 million. This represents a modest 3.4% lift over the same period last year.

Despite its profit growth and in light of the unprecedented market conditions created by the COVID-19 outbreak, the company is not declaring an interim dividend.

What were the drivers of this result?

Management advised that Clover has grown revenue in the USA by 57% and Europe by 31%, with new customers in infant formula and food applications.

It notes that European infant formula manufacturers are required to fortify their product for European sales with a minimum of 20mgDHA/100Kcal from February 2020. As such, they have spent the last six months transitioning their stocks to the higher DHA loading.

This is a positive for Clover as its unique Driphorm microencapsulated powder allows customers to achieve a higher loading without any sensory issues.

China update.

The Chinese infant formula market is reviewing draft legislation which, if introduced, would require infant formula sold in the country to contain a minimum of 15mgDHA/100Kcal.

While this is a potential positive for the company, the uncertainty about such future requirements means that manufacturers are cautious about building inventory levels.

In addition to this, China has stated its intention to increase local brands' share of the market, and there has also been a slow down in issuing of licenses to non-Chinese manufacturers supplying Chinese retail outlets. This is what the market has seen with Bubs Australia Ltd (ASX: BUB) and Bellamy's.

While it acknowledges that this might have a dampening effect on demand for Clover's products, it has been offset by the opening of additional bonded warehouses which facilitate the Cross Border E-commerce (CBEC) market for infant formula. This allows imported brands to access the Chinese market indirectly, without a retail license.

Outlook.

Pleasingly, management advised that the COVID-19 outbreak has had no impact on results in the first half of FY 2020 and is yet to have any impact on forward orders for the second half. At present, third quarter order rates are consistent with second half FY 2019 sales.

Assuming stability of the Chinese market, the company expects demand patterns from customers to continue in the second half of the year.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Clover Limited. The Motley Fool Australia has recommended BUBS AUST FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Smiling man with phone in wheelchair watching stocks and trends on computer
Share Market News

5 things to watch on the ASX 200 on Friday

The Australian share market looks set to end the week on a positive note.

Read more »

Three miners looking at a tablet.
Broker Notes

Does Macquarie prefer Rio Tinto, Fortescue or BHP shares heading into 2026?

BHP, Rio Tinto, or Fortescue? Macquarie only expects one of the three ASX mining stocks to outperform.

Read more »

Man sitting in a plane seat works on his laptop.
Opinions

Expert reveals 2 ASX stocks to sell — and 1 is a recent IPO

Toby Grimm from Baker Young shares his insights.

Read more »

Happy teen friends jumping in front of a wall.
Share Gainers

Guess which 4 ASX 200 shares are rocking new 52-week highs today!

Investors just sent these four ASX 200 shares to one-year-plus highs.

Read more »

A young woman holds her hand to her mouth in surprise as she reads something on her laptop.
Broker Notes

Why are Platinum shares rocketing 13% today?

This fund manager is getting a lot of love from investors today. Let's find out why.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Share Gainers

Why Evolution Mining, Orthocell, Platinum, and Turaco shares are charging higher

These shares are having a better day that most on Thursday.

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why CSL, Imricor, Jumbo, and Netwealth shares are falling today

These shares are under pressure on Thursday. But why?

Read more »

Three happy office workers cheer as they read about good financial news on a laptop.
Broker Notes

Morgans says these ASX stocks can rise 30% to ~50%

Let's see which shares could generate big returns for investors.

Read more »